BioSpace News Archive

Nurix Therapeutics Inc. today reported financial results for the second quarter ended May 31, 2021 and provided a corporate update.

Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, announced today the publication of their latest clinical utility study in Lupus & Science Medicine, found here: https://lupus.bmj.com/content/8/1/e000528.full.

Imara Inc., a clinical-stage biopharmaceutical company dedicated to developing and commercializing novel therapeutics to treat patients suffering from rare inherited genetic disorders of hemoglobin, announced that it has commenced a proposed underwritten public offering of $50 million of shares of its common stock.

Masimo (NASDAQ: MASI) will release second quarter 2021 financial results for the period ended July 3, 2021, after the market closes on Tuesday, July 27, 2021.

Genomma Lab Internacional today announced that it will report its Second Quarter 2021 results on Wednesday, July 28, 2021 after the Mexican Market (BMV) close.

Illumina, Inc. (NASDAQ:ILMN) today announced that it will issue results for the second quarter 2021 following the close of market on Thursday, August 5, 2021.

Health Canada previously advised Canadians not to use face masks that contain graphene after a preliminary assessment identified some potential for inhaled graphene particles to cause early lung effects in animals.

Kintor Pharmaceutical Limited today announced that the U.S. Food and Drug Administration (FDA) has cleared an Investigational New Drug (IND) application for its novel drug GT20029 for treating androgenetic alopecia (AGA) and acne subjects.

Blood plasma comprises platelets, autologous platelets and cytokines which arouse healing of soft tissue.

The microfluidics market is expected to reach US$ 43,398.7 million in 2027 from US$ 11,851.1 million in 2019; it is estimated to grow at a CAGR of 17.9% from 2020 to 2027.